tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

LXEO Stock Latest News

Lexeo Therapeutics price target lowered to $15 from $20 at Chardan
The FlyLexeo Therapeutics price target lowered to $15 from $20 at Chardan
15d ago
LXEO
Lexeo Therapeutics, Inc.: Promising Gene Therapy Advancements and Strategic Positioning in Cardiac Treatments
PremiumRatings
Lexeo Therapeutics, Inc.: Promising Gene Therapy Advancements and Strategic Positioning in Cardiac Treatments
15d ago
LXEO
Lexeo Therapeutics price target lowered to $9 from $15 at H.C. Wainwright
PremiumThe Fly
Lexeo Therapeutics price target lowered to $9 from $15 at H.C. Wainwright
15d ago
LXEO
Lexeo Therapeutics Reports Q2 2025 Financial Results
PremiumCompany Announcements
Lexeo Therapeutics Reports Q2 2025 Financial Results
15d ago
LXEO
Lexeo Therapeutics Appoints New Chief Financial Officer
PremiumCompany Announcements
Lexeo Therapeutics Appoints New Chief Financial Officer
16d ago
8K
LXEO
Lexeo Therapeutics reports Q2 EPS (60c) vs (64c) last year
PremiumThe FlyLexeo Therapeutics reports Q2 EPS (60c) vs (64c) last year
16d ago
LXEO
Meta, Microsoft upgraded: Wall Street’s top analyst calls
Premium
The Fly
Meta, Microsoft upgraded: Wall Street’s top analyst calls
1M ago
MP
CVX
Lexeo Therapeutics initiated with an Outperform at Oppenheimer
Premium
The Fly
Lexeo Therapeutics initiated with an Outperform at Oppenheimer
1M ago
LXEO
Lexeo Therapeutics announces FDA Breakthrough Therapy Designation for LX2006
PremiumThe Fly
Lexeo Therapeutics announces FDA Breakthrough Therapy Designation for LX2006
2M ago
LXEO
Lexeo Therapeutics Holds 2025 Annual Stockholders Meeting
PremiumCompany Announcements
Lexeo Therapeutics Holds 2025 Annual Stockholders Meeting
2M ago
8K
LXEO
Lexeo announces partnership to develop therapies using non-viral RNA platform
PremiumThe Fly
Lexeo announces partnership to develop therapies using non-viral RNA platform
2M ago
LXEO
Lexeo Therapeutics files to sell 41.63M shares of common stock for holders
PremiumThe Fly
Lexeo Therapeutics files to sell 41.63M shares of common stock for holders
3M ago
LXEO
Lexeo Therapeutics Announces $80M Private Placement Agreement
PremiumCompany AnnouncementsLexeo Therapeutics Announces $80M Private Placement Agreement
3M ago
8K
LXEO
Lexeo prices 20.8M shares at $2.8825 in private placement
Premium
The Fly
Lexeo prices 20.8M shares at $2.8825 in private placement
3M ago
LXEO
Lexeo Therapeutics, Inc.: Promising Gene Therapy Advancements and Superior Safety Profile Drive Buy Rating
Premium
Ratings
Lexeo Therapeutics, Inc.: Promising Gene Therapy Advancements and Superior Safety Profile Drive Buy Rating
4M ago
LXEO
Lexeo Therapeutics price target lowered to $15 from $23 at H.C. Wainwright
PremiumThe Fly
Lexeo Therapeutics price target lowered to $15 from $23 at H.C. Wainwright
4M ago
LXEO
RCKT
Lexeo Therapeutics: Strategic Focus and Promising Pipeline Drive Buy Rating
PremiumRatings
Lexeo Therapeutics: Strategic Focus and Promising Pipeline Drive Buy Rating
4M ago
LXEO
Lexeo Therapeutics Reports Increased Losses Amid R&D Expansion
PremiumCompany Announcements
Lexeo Therapeutics Reports Increased Losses Amid R&D Expansion
4M ago
LXEO
Lexeo Therapeutics price target lowered to $20 from $22 at Chardan
PremiumThe Fly
Lexeo Therapeutics price target lowered to $20 from $22 at Chardan
4M ago
LXEO
Lexeo Therapeutics reports Q1 EPS (99c), consensus (77c)
PremiumThe FlyLexeo Therapeutics reports Q1 EPS (99c), consensus (77c)
4M ago
LXEO
Controversial doctor Vinay Prasad named CBER director, STAT reports
Premium
The Fly
Controversial doctor Vinay Prasad named CBER director, STAT reports
4M ago
DYN
RNA
RBC sees Makary interview as potentially positive for biotech stocks
Premium
The Fly
RBC sees Makary interview as potentially positive for biotech stocks
4M ago
DYN
RNA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >